Arcus Biosciences, Inc. (RCUS)
25.14
-0.40
(-1.55%)
USD |
NYSE |
Sep 18, 16:00
25.14
0.00 (0.00%)
After-Hours: 19:50
Arcus Biosciences Price : 25.14 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | 25.31 | 25.92 | 25.05 | 25.54 | 2.011M |
| Sep 16, 2026 | 24.79 | 25.28 | 24.18 | 24.65 | 2.296M |
| Sep 15, 2026 | 23.89 | 24.35 | 23.31 | 24.32 | 1.928M |
| Sep 14, 2026 | 24.59 | 24.99 | 24.02 | 24.07 | 1.721M |
| Sep 11, 2026 | 26.50 | 26.58 | 24.32 | 24.59 | 4.277M |
| Sep 10, 2026 | 28.02 | 28.46 | 25.91 | 26.15 | 2.391M |
| Sep 09, 2026 | 28.71 | 29.30 | 28.20 | 28.49 | 1.828M |
| Sep 08, 2026 | 29.21 | 29.50 | 28.79 | 29.06 | 1.364M |
| Sep 04, 2026 | 29.64 | 30.10 | 29.40 | 29.66 | 736982.0 |
| Sep 03, 2026 | 29.92 | 30.20 | 29.20 | 30.13 | 681695.0 |
| Sep 02, 2026 | 30.17 | 31.47 | 29.32 | 29.85 | 1.234M |
| Sep 01, 2026 | 29.18 | 29.87 | 28.68 | 29.71 | 1.528M |
| Aug 31, 2026 | 28.89 | 29.34 | 28.23 | 29.28 | 1.106M |
| Aug 28, 2026 | 30.13 | 30.44 | 29.06 | 29.21 | 1.086M |
| Aug 27, 2026 | 30.75 | 31.01 | 30.36 | 30.59 | 806056.0 |
| Aug 26, 2026 | 31.34 | 31.46 | 30.30 | 30.76 | 685582.0 |
| Aug 25, 2026 | 30.11 | 31.58 | 30.11 | 31.57 | 655704.0 |
| Aug 24, 2026 | 30.27 | 30.91 | 29.38 | 30.12 | 1.296M |
| Aug 21, 2026 | 29.89 | 30.56 | 29.74 | 30.34 | 1.055M |
| Aug 20, 2026 | 29.88 | 30.39 | 28.94 | 29.52 | 1.546M |
| Aug 19, 2026 | 30.44 | 31.28 | 30.04 | 30.35 | 1.816M |
| Aug 18, 2026 | 29.23 | 29.86 | 28.94 | 29.51 | 896392.0 |
| Aug 17, 2026 | 29.32 | 30.04 | 28.92 | 29.56 | 2.175M |
| Aug 14, 2026 | 28.55 | 29.68 | 27.97 | 29.48 | 1.151M |
| Aug 13, 2026 | 29.13 | 29.30 | 28.62 | 28.86 | 984904.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Halozyme Therapeutics, Inc. | 112.65 |
| AVITA Medical, Inc. | 10.99 |
| Iovance Biotherapeutics, Inc. | 10.24 |
| Editas Medicine, Inc. | 2.71 |
| Recursion Pharmaceuticals, Inc. | 3.83 |
Price Related Metrics
| PS Ratio | 25.60 |
| PEG Ratio | -0.2779 |
| Price to Book Value | 6.882 |
| Earnings Yield | -15.53% |
| Market Cap | 3.193B |
| PEGY Ratio | -0.2779 |